Sommaire

• Introduction

  • ·First joint meeting of Société Francophone du Nerf Périphérique (SFNP) and Associazione Italiana per lo studio del Sistema Nervoso Periferico (ASNP)

    Page :1-1

    Jean-Marc Léger, Guido Cavaletti

    

• Scientific Organizing Committee

  • ·Pas de titre

    Page :2-2

    

• Plenary lectures

  • ·Recent advances in the pathophysiology of Charcot-Marie-Tooth disease

    Page :3-3

    Roman Chrast

    
  • ·Proteasome inhibition and peripheral nervous system damage

    Page :4-4

    Guido Cavaletti

    
  • ·Sensory neuronopathies : advances in classification and biomarkers

    Page :5-5

    Jean-Christophe Antoine

    
  • ·Small fibres, sodium channels and pain

    Page :6-6

    Giuseppe Lauria

    
  • ·Motor neuron syndrome : beyond the diagnosis of ALS

    Page :7-7

    Timothée Lenglet

    
  • ·Nodo-paranodopathy : a new category of neuropathy?

    Page :8-8

    Antonino Uncini

    

• Platform presentations

  • ·01 - Sphingolipid metabolism derangement as a potential target in peripheral myelin pathology

    Page :9-9

    Davide Visigalli, Giovanna Capodivento, Abdul Basit, Andrea Armirotti, Giulia Parodi, Angelo Schenone, Lucilla Nobbio

    
  • ·02 - Different us patterns in different types of charcot-marie-tooth (CMT) neuropathies

    Page :9-9

    Luca Padua, Marta Lucchetta, Daniele Coraci, Chiara Briani, Giuseppe Granata, Ilaria Paolasso, Marco Luigetti, Costanza Pazzaglia

    
  • ·03 - Clinical features and diagnosis of autonomic failure in familial amyloidotic polyneuropathy (FAP)

    Page :10-10

    Claudia Stancanelli, Valeria Iodice, Anna Mazzeo, Giuseppe Vita, Christopher James Mathias

    
  • ·04 - Teachings from the french database of ttr familial amyloid polyneuropathy (TTR-FAP): large genetic and phenotypic heterogeneity, usefulness of TTR gene testing

    Page :10-10

    David Adams, Zoia Mincheva, Cécile Cauquil, Clovis Adam, Pierre Lozeron, Anne Mantel, Sophie Valleix, Marie Theaudin, Catherine Lacroix

    
  • ·05 - Absence of antibodies to neurofascin in a large cohort of combined central and peripheral demyelination

    Page :10-11

    Andrea Cortese, Diego Franciotta, Jerome Devaux, Enrico Alfonsi, Luca Diamanti, Niccolo Visigalli, Elisabetta Zardini, Giusepp Piscosquito, Davide Pareyson, Enrico Marchioni

    Résumé Résumé Plan Plan
  • ·06 - Is gangliosides array a good tool to diagnose inflammatory neuropathies in a routine diagnostic setting? A prospective comparison between ELISA and array assays to detect anti-gangliosides antibodies

    Page :11-11

    Emilien Delmont, Henry Robb, Amy Davidson, Susan Halstead, Denggao Yao, Gavin Meehan, Hugh Willison

    
  • ·07 - Transcriptome analysis identifies TNFR1 and TLRs pathways in the IVIg response in chronic inflammatory demyelinating polyneuropathies

    Page :11-11

    Alexandra Richard, Jean-Christophe Corvol, Rabab Debs, Pauline Reach, Khadija Tahiri, Céline Labeyrie, David Adams, Fleur Aubart Cohen, Karine Viala

    
  • ·08 - Effects of intravenous immunoglobulins on gene expression of CIDP patients’skin biopsies: preliminary results

    Page :11-12

    Pinelopi Tsouni, Petrican-Adrian Panaite, Stefania Puttini, Nicolas Mermod, Andreas Steck, Thierry Kuntzer

    Résumé Résumé Plan Plan
  • ·09 - Topological positioning explains biophysics changes in pain-related Nav1.7 mutation

    Page :12-12

    Dimos Kapetis, Barbara Galbardi, Yang Yang, Catharina Faber, Ingemar Merkies, Steven Waxman, Giuseppe Lauria

    
  • ·10 - p.L1612P, a Novel Voltage-gated Sodium Channel Nav1.7 Mutation Inducing a Cold Sensitive Paroxysmal Extreme Pain Disorder

    Page :12-12

    Marc Suter, Zahurul Bhuiyan, Cédric Laedermann, Thierry Kuntzer, Muriel Schaller, Maurice Stauffacher, Eliane Roulet, Hugues Abriel, Isabelle Decosterd, Christian Wider

    
  • ·11 - Small Fiber Neuropathies associated with gain of function Nav1.7 mutations

    Page :12-13

    Hayet Salhi, Pascale Fanen, Benoît Funalot, Valérie Raclin, Samar Ayache, Yasmine Baba Amer, François Jerôme Authier, Jean Pascal Lefaucheur, Alain Créange

    Résumé Résumé Plan Plan
  • ·12 - Diagnosis of Small-fiber neuropathy using the quantitative evaluation of axon reflex-mediated vasodilation

    Page :13-13

    Thierry Kuntzer, Irène Calero-Romero, Bernard Waeber, Francois Feihl

    
  • ·13 - Restoring natural sensory feedback in real-time bidirectional hand prostheses

    Page :13-13

    Giuseppe Granata, Stanisa Raspopovic, Marco Capogrosso, Francesco Maria Petrini, Luca Padua, Eduardo Fernandez, Silvestro Micera, Paolo Maria Rossini

    
  • ·14 - Neurophysiological differential diagnosis between sensory neuronopathy and axonal neuropathy

    Page :13-13

    Jean-Pascal Lefaucheur, Hayet Salhi, Florence Canouï-Poitrine, Samar S Ayache, Alain Créange

    
  • ·15 - Heterogeneity of polyneuropathy associated with anti-MAG antibodies

    Page :14-14

    Laurent Magy, Raphaël Kaboré, Stéphane Mathis, Christiane Caudie, Prisca Lebeau, Karima Ghorab, Jean-Michel Vallat

    
  • ·16 - Long-term efficacy of rituximab in igm anti-myelin-associated glycoprotein neuropathy: RIMAG study follow-up

    Page :14-14

    Ruxandra Iancu Ferfoglia, Raquel Guimarães-Costa, Karine Viala, Lucile Musset, Jean Neil, Benoit Marin, Jean-Marc Léger

    
  • ·17 - Guillain – Barré and Miller Fisher syndromes : new diagnostic classification

    Page :14-14

    M Nobuhiro Yuki

    
  • ·18 - HOME LINK : A telemedicine and telehealth system for home-based IVIg treatment

    Page :14-15

    Nabil Moumane, Pierre Lozeron, Karine Viala, Guilhem Solé, Emilien Delmont, Gwendal Le Masson

    Résumé Résumé Plan Plan
  • ·19 - Chemotherapy induced peripheral neurotoxicity – an issue that should not be forgotten neuropathic pain

    Page :15-15

    Paola Alberti,

    
  • ·20 - Nonsystemic vasculitis neuropathy: initial presentation and long term follow-up in a monocentric series of 20 patients

    Page :15-15

    Marion Quirins, Clovis Adam, Cécile Cauquil, Pierre Lozeron, Catherine Lacroix, David Adams, Marie Théaudin

    
  • ·21 - The French peripheral neuropathy database project

    Page :15-16

    Jean-Christophe Antoine, Laurent Magy, Gwendal Lemasson, David Adams, Guillaume Nicolas, Karine Viala, Shahram Attarian, Benoit Funalot, Alain Créange

    Résumé Résumé Plan Plan

• Poster presentations

  • ·P01 - Prognostic factors and health-related quality of life (HRol) in immune-mediated peripheral neuropathies

    Page :17-17

    Giuliana Galassi, Manuela Tondelli, Alessandra Ariatti, Franco Valzania, Francesca Benuzzi, Paolo Nichelli

    
  • ·P02 - Multicenter protocol on the role of ultrasound in immune-mediated neuropathies

    Page :17-17

    Ilaria Paolasso, Lisa Hobson-Webb, Chiara Briani, Carmen Erra, Giuseppe Granata, Daniele Coraci, Luca Padua

    
  • ·P03 - Description and comparison of ultrasonographics features in inflammatory chronic démyélinating polyradiculoneuropathy, multifocal motor neuropathy and lewis sumner syndrome

    Page :18-18

    Quesnel Laetitia, Vial Christophe, Bouhour Françoise

    
  • ·P04 - Chronic immune mediated neuropathies and physical activity Quality of life, coping, motivation and self-esteem : Multi-centred approach

    Page :18-18

    Jean-Philippe Plançon

    
  • ·P05 - CIDP and tremor: possible relationship between electrophysiological data, presence of auto antibodies and response to treatment

    Page :18-18

    Raquel Guimarães-Costa, Ruxandra Iancu Ferfoglia, Karine Viala, Lucile Musset, Emmanuelle Apartis, Isabel Illa, Jean-Marc Léger

    
  • ·P06 - Chronic inflammatory demyelinating polyradiculo-neuropathy and extraocular eye muscles involvement: a rare association

    Page :19-19

    Schirinzi Erika, Lucchesi Cinzia, Pesaresi Ilaria, Figus Michele, Pasquali Livia, Siciliano Gabriele

    
  • ·P07 - Efficacy and tolerability of different brand of IVIg in the maintenance treatment of chronic immune mediated neuropathy

    Page :19-19

    Francesca Gallia, Claudia Balducci, Davide Di Pietro, Eduardo Nobile-Orazio

    
  • ·P08 - Subcutaneous immunoglobulins long-term efficacy in mmN and CIDP patients

    Page :19-19

    Aristide Merola, Alberto Romagnolo, Erdita Peci, Leonardo Lopiano, Dario Cocito

    
  • ·P09 - Is the responsiveness to IVIG or corticosteroids predictive for treatment dependence in CIDP?

    Page :20-20

    Fiore Manganelli, Antonietta Topa, Rosa Iodice, Chiara Pisciotta, Lucio Santoro

    
  • ·P10 - Fitz-Hugh-Nagumo equations in nerve models and node-pathology / moesin-complex novel neuropathies

    Page :20-20

    Sabino Guillermo Echebarria Mendieta

    
  • ·P11 - Could Electroneuromyographic studies predict prognosis in anti MAG neuropathies?

    Page :20-20

    Benoit Pegat, Morgane Pihan, Guillemette Fayet, Yann Pereon, Armelle Magot

    
  • ·P12 - Anti-mag antibodies neuropathy: does response to rituximab differ depending on the associated hematological disease?

    Page :20-21

    Marta Campagnolo, Chiara Dalla Torre, Marta Lucchetta, Tamara Berno, Susanna Ruggero, Elisabetta Toffanin, Renato Zambello, Chiara Briani

    Résumé Résumé Plan Plan
  • ·P13 - Predictive factors of the clinical response to rituximab in patients with anti-MAG neuropathy

    Page :21-21

    Sebastien Gazzola, Jérôme Franques, Joseph Boucraut, Emmanuelle Salort-Campana, Annie Verschueren, Emilien Delmont, Emmanuel Sagui, Anne-Michèle Hubert, Jean Pouget, Shahram Attarian

    
  • ·P14 - Correlation between the serum levels of VEGF and the severity of the polyneuropathy in POEMS syndrome: a retrospective study in 30 patients

    Page :21-21

    Laetitia d’Aligny, Lucile Musset, Karine Viala, Thierry Maisonobe, Emmanuel Fournier, Timothée Lenglet

    
  • ·P15 - Persisting MRI inflammatory changes in nerve roots of a patient with CANOMAD after 32 years of time course evolution

    Page :21-22

    Jérôme Hodel, Hayet Salhi, Mohamed Abdellaoui, Jean-Pascal Lefaucheur, Alain Créange

    Résumé Résumé Plan Plan
  • ·P16 - Immune-mediated neuropathy after hematopoietic stem cell transplantation

    Page :22-22

    Alaina Bordena, Nicolas Weiss, Etienne Paubelle, Jean-Paul Vernant, Pauline Reach, Rabab Debs, Benjamin Rohaut, Thierry Maisonobe, Régine Morizot-Koutlidis, Karine Viala

    
  • ·P17 - Clinical spectrum, causes and evolution of disabling neuropathies in patients with hematopoietic stem cell transplantation on a 20 years period

    Page :22-22

    Adeline Not, Céline Labeyrie, Guillemette Beaudonnet, Jean-Henri Bourhis, David Adams, Christian Denier, Cécile Cauquil

    
  • ·P18 - Closed nerve trauma causing neuroma. Is ultrasound nerve size related to function (clinically and neurophysiologically assessed)?

    Page :22-23

    Daniele Coracia, Costanza Pazzaglia, Carmen Erra, Giuseppe Granata, Ilaria Paolasso, Luca Padua

    Résumé Résumé Plan Plan
  • ·P19 - Unexpected nerve ultrasound findings in a patient with Friedreich’s ataxia

    Page :23-23

    Marta Lucchetta, Mario Cacciavillani, Alessandro Salvalaggio, Roberto Gasparotti, Chiara Briani

    
  • ·P20 - Role of OCT2 in the development of peripheral neurotoxicity induced by cisplatin in C57BL/6 mice model

    Page :23-23

    Alessia Chiorazzi, Annalisa Canta, Valentina Alda Carozz, Cristina Meregalli, Cecilia Ceresa, Norberto Oggioni, Paola Marmiroli, Guido Cavaletti

    
  • ·P21 - Olive oil polyphenol rich extract (OMP) prevents experimental chemotheraphy-induced peripheral neuropathy (CINP)

    Page :23-24

    Roberto Bianchi, Carla Porretta-Serapiglia, Michela Maria Taiana, Raffaella Lombardi, Jenny Sassone, Norberto Oggioni, Annalisa Canta, Cristina Meregalli, Guido Cavaletti, Giuseppe Lauria

    Résumé Résumé Plan Plan
  • ·P22 - Lenalidomide long-term neurotoxicity: a 2-years neurophysiological follow-up study in patients with relapsed/ refractory multiple myeloma

    Page :24-24

    Chiara Dalla Torre, Mario Cacciavillani, Marta Campagnolo, Marta Lucchetta, Tamara Berno, Elena De March, Renato Zambello, Chiara Briani

    
  • ·P23 - Aging and peripheral nervous system: a neurophysiological, morphological and morphometric study in C57BL/6 MICE

    Page :24-24

    Annalisa Canta, Valentina Alda Carozzi, Cristina Meregalli, Alessia Chiorazzi, Mario Bossi, Norberto Oggioni, Paola Marmiroli, Guido Cavaletti

    
  • ·P24 - Characterisation of nerve and microvessels lesion and recovery in streptozotocin diabetic mice after permanent femoral artery ligation

    Page :24-25

    Pierre Lozerona, Chris Sorel Mantsounga, Dong Broqueres Youa, Anthony Dohan, Marc Polivka, Jean-Sebastien Silvestre, Nathalie Kubis, Bernard Lévy

    Résumé Résumé Plan Plan
  • ·P25 - Painful neuropathies are NOT due to small fibre lesion

    Page :25-25

    Jean-Pascal Lefaucheur, Hayet Salhi, Marc Sorel, Colette Goujon, Alain Créange

    
  • ·P26 - What is the best neurophysiological approach for the diagnosis of small-fiber neuropathy?

    Page :25-25

    Jean-Pascal Lefaucheur, Hayet Salhi, Sophie Ng Wing Tin, Hela G Zouari, Violaine Planté-Bordeneuve, Alain Créange

    
  • ·P27 - SUDOSCAN as an assessment tool for sudomotor function: normative data in children

    Page :25-26

    Tristan Bosquet, Armelle Magot, Laurène Leclair-Visonneau, Guillemette Fayet, Christèle Gras-Le Guen, Antoine Hamel, Yann Péréon

    Résumé Résumé Plan Plan
  • ·P28 - Quick and non invasive sweat function assessment to evaluate small fiber neuropathy in Fabry disease

    Page :26-26

    Pauline Sahuc, Bertrand Dussol, Laure Swiader, Roselyne Froissard, Jean Henri Calvet, Jean Pouget, Jerome Franques

    
  • ·P29 - Isolated sensory neuropathy widens the phenotypic spectrum of POLG1-related disorders

    Page :26-26

    Giuseppe Piscosquito, Ettore Salsano, Eleonora lamantea, Davide Rossi Sebastiano, Costanza Lamperti, Davide Pareyson

    
  • ·P30 - Reduced neurofilament expression in cutaneous nerve fibers of cmT2E patients

    Page :26-27

    Chiara Pisciotta, Yunhong Bai, Kathryn Brennan, Tiffany Grider, Shawna Feely, Suola Wang, Steven Moore, Michael Shy

    Résumé Résumé Plan Plan
  • ·P31 - Nerve ultrasound in patients with cmT1C : description of three cases

    Page :27-27

    Carmen Erraa, Marco Luigetti, Mario Sabatelli, Emilia Bellone, Gian Maria Fabrizi, Luca Padua, Giuseppe Granata

    
  • ·P32 - High frequency of SH3TC2 mutations in early-onset CMT4

    Page :27-27

    Giuseppe Piscosquito, Paola Saveri, Stefania Magri, Daniela Di Bella, Micaela Milani, Claudia Ciano, Claudia Gandioli, Isabella Moroni, Franco Taroni, Davide Pareyson

    
  • ·P33 - The design of a phase III trial to confirm efficacy and safety of PXT3003 for the treatment of Charcot-Marie-Tooth Disease Type 1A

    Page :27-28

    Shahram Attarian, Michael Sereda, Laurent Magy, Peter Young, Marianne De Visser, Beatrice Van Paassen, David Cornblath, Viviane Bertrand, Catherine Scart Grès, Daniel Cohen

    Résumé Résumé Plan Plan
  • ·P34 - An Exploratory Randomised Double-Blind and Placebo-Controlled Phase 2 Study of a Low-Dose Combination of Baclofen, Naltrexone and Sorbitol (PXT3003) in Patients with Charcot-Marie-Tooth Disease Type 1A

    Page :28-28

    Shahram Attarian, Jean-Michel Vallat, Laurent Magy, Viviane Bertrand, Jonas Mandel, Catherine Scart-Grès, Mickaël Guedj, Ilya Chumakov, Daniel Cohen

    
  • ·P35 - A Meta-Analysis of Randomized Placebo-Controlled Phase 2 Trials in Patients with CMT1A

    Page :28-28

    Jonas Mandel, Viviane Bertrand, Philippe Lehert, Ilya Chumakov, Catherine Scart-Grès, Mickaël Guedj, Daniel Cohen

    
  • ·P36 - Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates PMP22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy

    Page :29-29

    Ilya Chumakov, Aude Milet, Nathalie Cholet, Gwenaël Primas, Michael Sereda, Mickael Guedj, Rodolphe Hajj, Serguei Nabirotchkin, Daniel Cohen